News

download8

EndoGlow Has Received Notification that the European Patent Office has Formally Announced its intention to grant a European Patent for our GreenEgg and Tissue Reveal Technology! Expect a lot more great news from EndoGlow in 2022!

EndoGlow has received notification that the European Patent Office has formally announced its intention to grant a European patent for our GreenEgg and Tissue Reveal Technology! Expect a lot more great news from EndoGlow in 2022! [Endoglow LinkedIn announcement, January 14, 2022]
JelikaLiteLogo

CNYBAC MDIC 2021 Team JelikaLite to Participate at 2nd Annual Princeton Women Founders Startup Showcase

Princeton Entrepreneurship Council is pleased to present the 2nd annual Women Founders Startup Showcase. This year’s event will feature six outstanding Princeton founders who represent faculty/postdoc, graduate alumna, and undergraduate alumnae across the Princeton entrepreneurial community.Marya...
CNYBAC MDIC 2021 Team JelikaLite to Participate at 2nd Annual Princeton Women Founders Startup Showcase
download7

CNYBAC Client Aurie Receives FDA Safer Technology Designation for its Reusable Intermittent Catheter System

Published By: Aurie Oct 11, 2021NEW YORK, October 11, 2021 — Aurie, a human-centered medical device company developing an automated reusable self-catheter system, announced today that the Aurie Reusable Intermittent Catheter System has received the Safer Technology designation from the U. S. Food ...
CNYBAC Client Aurie Receives FDA Safer Technology Designation for its Reusable Intermittent Catheter System
JelikaLiteLogo2

JelikaLite, a CNYBAC MDIC 2021 Team, Granted FDA Breakthrough Device Designation:

Provided by Business Wire- 1/6/21 NEW YORK--(BUSINESS WIRE)--JelikaLite Corp, a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) has granted the Breakthrough Device Designation to its Cognilum System for the reduction of symptoms of moderate to severe auti...
JelikaLite, a CNYBAC MDIC 2021 Team, Granted FDA Breakthrough Device Designation:
download6

More Great News for CNYBAC Client Zetagen Therapeutics: Zetagen Announces the National Cancer Institute (NCI) has Awarded Zetagen with a Phase II $2 Million Grant for the Expanded Development of ZetaMet

ZETAGEN THERAPEUTICS AWARDED $2 MILLION USD GRANT FROM THE NATIONAL CANCER INSTITUTE (NCI) FOR PHASE 2 STUDY OF ZETAMET™ FOR TREATMENT OF METASTATIC BONE CANCERS(Zetagen Therapeutics Press Release:  December 13, 2021) Zetagen Therapeutics, Inc., a private, clinical-stage, biopharmaceutical comp...
More Great News for CNYBAC Client Zetagen Therapeutics: Zetagen Announces the National Cancer Institute (NCI) has Awarded Zetagen with a Phase II $2 Million Grant for the Expanded Development of ZetaMet

CNY Biotech Accelerator 2021 Medical Device Innovation Challenge Team, MindTrace, Accepted into AlphaLab Health 2021-2022 Cohort

Provided  By: PITTSBURGH (PRWEB) DECEMBER 03, 2021Healthcare and life sciences accelerator AlphaLab Health today announced the second cohort of start-up companies to participate in their program. The companies were competitively selected to participate in a six-month program that will help them ...
CNY Biotech Accelerator 2021 Medical Device Innovation Challenge Team, MindTrace, Accepted into AlphaLab Health 2021-2022 Cohort
download 2

Cayuga County Partners with Local Syracuse Company for Community COVID Testing Site

Cayuga County Partners with Local Syracuse Company for Community COVID Testing Site  Cayuga County has partnered with Syracuse-based Quadrant Biosciences to open a COVID testing site for symptomatic members of the community. The new site, located in the old Joann Fabrics in the Fingerlakes Mall at ...
Cayuga County Partners with Local Syracuse Company for Community COVID Testing Site
download5

CNYBAC Client, Zetagen Therapeutics, Wins Special Designation for Biologic Technology Aimed at inhibiting Cancerous Tumor Growth

Article posted by Upstate News Darrel Geddes 12/9/21Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company that works out of Upstate Medical University’s Central New York Biotech Accelerator (CNYBAC), has received Breakthrough Device designation from the Centers for Devices and...
CNYBAC Client, Zetagen Therapeutics, Wins Special Designation for Biologic Technology Aimed at inhibiting Cancerous Tumor Growth

CNYBAC is Very Excited to Announce Client Carapace Analytics’ Selection to Compete in the FuzeHub Commercialization Competition at the NYSTAR Innovation Summit

CNYBAC is very excited to announce client Carapace Analytics’ selection to compete in the FuzeHub Commercialization Competition at the NYSTAR Innovation Summit next week: https://nysinnovationsummit.com/ Carapace Analytics is developing solutions to maintain the health of older adults through ind...
CNYBAC is Very Excited to Announce Client Carapace Analytics’ Selection to Compete in the FuzeHub Commercialization Competition at the NYSTAR Innovation Summit
download 1

Congratulations CNYBAC clients, Quadrant Biosciences and Zetagen Therapeutics Named as CNY Economic Champions at CenterState CEO’s Virtual 2021 Economic Champions Celebration

Video Posted from Centerstate CEOhttps://www.youtube.com/watch?v=LaYBAZYH55U  https://www.centerstateceo.com/news-events/centerstate-ceo-celebrates-2021-economic-champions
Congratulations CNYBAC clients, Quadrant Biosciences and Zetagen Therapeutics Named as CNY Economic Champions at CenterState CEO’s Virtual 2021 Economic Champions Celebration

1 2 3 4 5 6